Inhibition of the target of rapamycin signalling pathway by genetic or pharmacological intervention extends lifespan in invertebrates, including yeast, nematodes and fruitflies.Researchers reported that rapamycin extended median and maximal lifespan of both male and female mice when fed beginning at 600 days of age. On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. The effect was seen at three independent test sites in genetically heterogeneous mice, chosen to avoid genotype-specific effects on disease susceptibility. Disease patterns of rapamycin-treated mice did not differ from those of control mice. In a separate study, rapamycin fed to mice beginning at 270 days of age also increased survival in both males and females. Thus, rapamycin may extend lifespan by postponing death
from cancer, by retarding mechanisms of ageing, or both.
from cancer, by retarding mechanisms of ageing, or both.
No comments:
Post a Comment